摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to particular compounds, which demonstrate inhibiting activity with respect to ERK, whose structure formula is given in description, to their pharmaceutically acceptable salts, based on them pharmaceutical composition and their application for treatment of cancer, mediated by ERK activity.EFFECT: obtaining compounds, which demonstrate inhibiting activity with respect to ERK.5 cl |